Full width 1920x800_2.jpg

Future proofing

with the Medisca

MAZ® mixer

With patented capabilities, minimal to no maintenance, and versatility without calibration, the MAZ mixer is the result of 10+ years of research and development, established operating procedures, and a growing library of 200+ formulas—bridging the gaps in pharmaceutical compounding and consumer goods production.

Shop now

MAZ mixersAccessories
KK300 2
KK-300SS
KK400 2
KK-400W
KK1000 2
KK-1000
Compare MAZ 2
Compare MAZ mixers

Speak with

an expert

Our dedicated MAZ specialists will get to know your unique needs and design custom-tailored processes for a smooth transition that optimizes your day-to-day operations.

Book a meeting
MAZ support team

Key capabilities

Homogenization
In a matter of seconds, homogenize creams, gels, ointments, liquids, and powders with uniform distribution of active ingredients. Evidence supporting this can be seen in HPLC assay results that tested the top, middle, and bottom layers of a cream containing baclofen, bupivacaine HCl, cyclobenzaprine, and diclofenac - and found relative standard deviations (RSD) of less than 3% and as low as 0% when mixed in the MAZ mixer1. Similar results were also seen when mixing T3 and T4 in a powder blend, resulting in an RSD value of less than 1.5%2.

Explore more

MAZ resources

Compare features and performance across MAZ models, and get answers to your questions about functionality and usage.

Compare MAZ 2
Compare MAZ mixers
MAZ FAQ
Explore MAZ FAQs

Inspiring stories from

our customers

"I have been compounding for 15 years, starting with an ointment mill, then on to an EMP. The MAZ was a game-changer for compounding.

My productivity has multiplied along with our business. The volume I can produce with a MAZ in a day is far more than any other piece of equipment out there."

Amanda Niblett, Technician

Paris Apothecary

Need help

getting started?

Get in touch today

References:

  1. Medisca. (2016). Stability-indicating HPLC analysis of active ingredient concentration throughout the preparation.
  2. Medisca. (2023). Stability-indicating HPLC analysis of levothyroxine and liothyronine.

  3. Medisca (2017). Deaerating capability of the MAZ as assessed by measuring specific gravity.

  4. Medisca. (2016). Particle size testing with the ointment mill and Medisca® MAZ Mixer.
*For clarity, Medisca does not supply cannabis nor its derivatives. Medisca makes no representations regarding the legality of any uses of the MAZ mixer in connection with the processing of cannabis. In all cases it is the responsibility of the customer to be knowledgeable of the prohibitions and legal requirements attendant to the use of cannabis in their respective jurisdiction, and to abide by any such legal restrictions. The use of the MAZ mixer is at the sole risk and responsibility of the customer.